메뉴 건너뛰기
Primary Care Companion to the Journal of Clinical Psychiatry
Volumn 7, Issue 2, 2005, Pages 74-75
Interferon-α treatment of hepatitis C patients with psychiatric illness: Evidence-based risk-benefit assessment [2]
Author keywords

[No Author keywords available]
Indexed keywords

ALPHA INTERFERON;
EID: 28944451441     PISSN: 15235998     EISSN: None     Source Type: Journal    
DOI: 10.4088/pcc.v07n0207b     Document Type: Letter
Times cited : (6)
References (8)
  • 1
    • 0038350751 scopus 로고    scopus 로고
    • The five-site health and risk study of blood-borne infections among persons with severe mental illness
    • Rosenberg SD, Swanson JW, Wolford GL, et al. The five-site health and risk study of blood-borne infections among persons with severe mental illness. Psychiatr Serv 2003;54:827-835
    • (2003) Psychiatr Serv , vol.54 , pp. 827-835
    • Rosenberg, S.D.1    Swanson, J.W.2    Wolford, G.L.3
  • 2
    • 28944449650 scopus 로고    scopus 로고
    • The prevalence of psychiatric disorders in patients with chronic hepatitis C
    • Rifai MA, Moles JK, Van Der Linden BJ. The prevalence of psychiatric disorders in patients with chronic hepatitis C [abstract]. Psychosomatics 2003;44:142-143
    • (2003) Psychosomatics , vol.44 , pp. 142-143
    • Rifai, M.A.1    Moles, J.K.2    Van Der Linden, B.J.3
  • 3
    • 0034759752 scopus 로고    scopus 로고
    • Psychiatric comorbidity among hepatitis C-positive patients
    • Yovtcheva SP, Rifai MA, Moles JK, et al. Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics 2001;42:411-415
    • (2001) Psychosomatics , vol.42 , pp. 411-415
    • Yovtcheva, S.P.1    Rifai, M.A.2    Moles, J.K.3
  • 4
    • 1542378867 scopus 로고    scopus 로고
    • Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose
    • Hadziyannis SJ, Sette H Jr, Morgan TR, et al. Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004;140:346-355
    • (2004) Ann Intern Med , vol.140 , pp. 346-355
    • Hadziyannis, S.J.1    Sette Jr., H.2    Morgan, T.R.3
  • 5
    • 0037179698 scopus 로고    scopus 로고
    • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
    • Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-982
    • (2002) N Engl J Med , vol.347 , pp. 975-982
    • Fried, M.W.1    Shiffman, M.L.2    Reddy, K.R.3
  • 6
    • 0344211831 scopus 로고    scopus 로고
    • A prospective study of neuropsychiatric symptoms associated with interferon-α-2b and ribavirin therapy for patients with chronic hepatitis C
    • Dieperink E, Ho SB, Thuras P, et al. A prospective study of neuropsychiatric symptoms associated with interferon-α-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 2003;44:104-112
    • (2003) Psychosomatics , vol.44 , pp. 104-112
    • Dieperink, E.1    Ho, S.B.2    Thuras, P.3
  • 7
    • 0037308288 scopus 로고    scopus 로고
    • Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups
    • Schaefer M, Schmidt F, Folwaczny C, et al. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003;37:443-451
    • (2003) Hepatology , vol.37 , pp. 443-451
    • Schaefer, M.1    Schmidt, F.2    Folwaczny, C.3
  • 8
    • 1842479859 scopus 로고    scopus 로고
    • Diagnosis, management, and treatment of hepatitis C
    • Strader D, Wright T, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004;39:1147-1171
    • (2004) Hepatology , vol.39 , pp. 1147-1171
    • Strader, D.1    Wright, T.2    Thomas, D.L.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.